Two New Piperazine-Triones from a Marine-Derived Streptomycetes sp. Strain SMS636.
Xiuli XuJiahui HanRui LinSteven W PolyakFu-Hang SongPublished in: Marine drugs (2019)
Two new piperazine-triones lansai E and F (1, 2), together with four known secondary metabolites lansai D (3), 1-N-methyl-(E,Z)-albonoursin (4), imidazo[4,5-e]-1,2,4-triazine (5), and streptonigrin (6) were isolated from a deep-sea-derived Streptomycetes sp. strain SMS636. The structures of the isolated compounds were confirmed by comprehensive spectroscopic analysis, including HRESIMS, 1D and 2D NMR. Compound 4 exhibited moderate antibacterial activities against Staphylococcus aureus and methicillin resistant S. aureus (MRSA) with Minimum Inhibitory Concentration (MIC) values of 12.5 and 25 μg/mL, respectively. Compound 6 displayed significant antibacterial activities against S. aureus, MRSA and Bacillus Calmette-Guérin (BCG) with MIC values of 0.78, 0.78 and 1.25 μg/mL, respectively.
Keyphrases
- staphylococcus aureus
- methicillin resistant staphylococcus aureus
- biofilm formation
- high resolution
- silver nanoparticles
- molecular docking
- ms ms
- magnetic resonance
- high intensity
- escherichia coli
- wound healing
- cystic fibrosis
- muscle invasive bladder cancer
- solid phase extraction
- molecular dynamics simulations
- simultaneous determination